Your search returned 2 results.

Results
	1.	A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia. [electronic resource] by Mackay, H J Buckanovich, R J Hirte, H Correa, R Hoskins, P Biagi, J Martin, L P Fleming, G F Morgan, R Wang, L Polintan, R Oza, A M Producer: 20120713 In: Gynecologic oncology vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase II trial of vorinostat in advanced melanoma. [electronic resource] by Haas, N B Quirt, I Hotte, S McWhirter, E Polintan, R Litwin, S Adams, P D McBryan, T Wang, L Martin, L P vonMehren, M Alpaugh, R K Zweibel, J Oza, A Producer: 20150207 In: Investigational new drugs vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search